MedPath

ACYCLOVIR

Acyclovir Capsules

Approved
Approval ID

f5174611-2734-4610-b12f-eb5a7f39d7b6

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 5, 2011

Manufacturers
FDA

Boscogen, Inc.

DUNS: 932611189

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Acyclovir

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62033-0204
Product Classification
G
Generic Name
Acyclovir
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 5, 2011
FDA Product Classification

INGREDIENTS (5)

AcyclovirActive
Quantity: 200 mg in 1 1
Code: X4HES1O11F
Classification: ACTIB
Sodium Starch Glycolate Type A PotatoInactive
Quantity: 21.15 mg in 1 1
Code: 5856J3G2A2
Classification: IACT
Lactose MonohydrateInactive
Quantity: 195.5 mg in 1 1
Code: EWQ57Q8I5X
Classification: IACT
Magnesium StearateInactive
Quantity: 4.23 mg in 1 1
Code: 70097M6I30
Classification: IACT
Sodium Lauryl SulfateInactive
Quantity: 2.12 mg in 1 1
Code: 368GB5141J
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ACYCLOVIR - FDA Drug Approval Details